MULTIPLE SCLEROSIS Oral laquinimod for MS-bringing the brain into focus

被引:8
作者
Brueck, Wolfgang [1 ]
Vollmer, Timothy [2 ]
机构
[1] Univ Gottingen, Univ Med Ctr Gottingen, Inst Neuropathol, D-37075 Gottingen, Germany
[2] Univ Colorado, Dept Neurol, Aurora, CO 80045 USA
关键词
D O I
10.1038/nrneurol.2013.234
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Currently approved multiple sclerosis (MS) treatments mainly target the peripheral immune system, thereby reducing relapse rates and MRI markers of inflammation. A recent phase III trial indicates that laquinimod, a new orally active immunomodulator, has a CNS-intrinsic mode of action that is independent of effects on the peripheral immune response.
引用
收藏
页码:664 / 665
页数:3
相关论文
共 8 条
[1]  
Bruck W., JAMA NEUROL, DOI DOI 10.1001/JAMANEUR0L.2013.3510
[2]   Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination [J].
Brueck, Wolfgang ;
Pfoertner, Ramona ;
Trinh Pham ;
Zhang, Jingya ;
Hayardeny, Liat ;
Piryatinsky, Victor ;
Hanisch, Uwe-Karsten ;
Regen, Tommy ;
van Rossum, Denise ;
Brakelmann, Lars ;
Hagemeier, Karin ;
Kuhlmann, Tanja ;
Stadelmann, Christine ;
John, Gareth R. ;
Kramann, Nadine ;
Wegner, Christiane .
ACTA NEUROPATHOLOGICA, 2012, 124 (03) :411-424
[3]  
Brück W, 2012, EXPERT REV CLIN PHAR, V5, P245, DOI [10.1586/ECP.12.12, 10.1586/ecp.12.12]
[4]   Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis [J].
Comi, Giancarlo ;
Jeffery, Douglas ;
Kappos, Ludwig ;
Montalban, Xavier ;
Boyko, Alexey ;
Rocca, Maria A. ;
Filippi, Massimo .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (11) :1000-1009
[5]  
Filippi M., J NEUROL NEUROSUR PS, DOI DOI 10.1136/JNNP-2013-306132
[6]   Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis [J].
Jolivel, Valerie ;
Luessi, Felix ;
Masri, Joumana ;
Kraus, Stefan H. P. ;
Hubo, Mario ;
Poisa-Beiro, Laura ;
Klebow, Sabrina ;
Paterka, Magdalena ;
Yogev, Nir ;
Tumani, Hayrettin ;
Furlan, Roberto ;
Siffrin, Volker ;
Jonuleit, Helmut ;
Zipp, Frauke ;
Waisman, Ari .
BRAIN, 2013, 136 :1048-1066
[7]   Pathology and disease mechanisms in different stages of multiple sclerosis [J].
Lassmann, Hans .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 333 (1-2) :1-4
[8]   Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity [J].
Schulze-Topphoff, Ulf ;
Shetty, Aparna ;
Varrin-Doyer, Michel ;
Molnarfi, Nicolas ;
Sagan, Sharon A. ;
Sobel, Raymond A. ;
Nelson, Patricia A. ;
Zamvil, Scott S. .
PLOS ONE, 2012, 7 (03)